![](https://www.microbiometimes.com/wp-content/uploads/2018/04/writing-1149962_1920-326x245.jpg)
Pharma & Human Health
Optibiotix Health plc Signs 5 year Exclusive Agreement with Trigen Pharma
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces it has entered into a five year distribution agreement with Trigen Pharma International (Pvt) […]